Testing effectiveness (Phase 2)Ended earlyNCT02677688
What this trial is testing
Autologous EBV-specific Cytotoxic T Cells for the Treatment of Systemic Lupus Erythematosus (SLE)
Who this might be right for
Serologically Active Adult Systemic Lupus Erythematosus
Nantes University Hospital 9